Apollo Implant Componentssp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-07-12
Share capital
10,000.00 PLN
Registered address
ul. Konopna 16, 95-200 Pabianice, Poland
Electronic delivery address
AE:PL-72350-49669-BBSAU-19

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$3,728

Filing timeliness

Financial statements were filed on time, on average 44 days early.

  • 202522/04/2026
  • 202411/07/2025
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods489 / 1,141
Top 43%
Division · Wholesale trade6,451 / 20,010
Top 32%
City · Pabianice59 / 365
Top 16%
Voivodeship · Łódzkie2,851 / 15,331
Top 19%
Country · Poland53,412 / 298,279
Top 18%

Results vs industry

Revenue
This companyUSD 2.49mMedianUSD 1.07mAverageUSD 22.39m
Net profit
This companyUSD 23.45kMedianUSD 37.46kAverageUSD 877.59k
Operating costs
This companyUSD 2.45mMedianUSD 932.14kAverageUSD 21.07m
Assets
This companyUSD 426.43kMedianUSD 609.79kAverageUSD 11.84m

Authorized Representatives

Aleksander Daniel Orzełowskiage 49 – President of the Management Board
Anna Magdalena Wołosz – Attorney-in-fact (sole)

Manner of representation

Two members of the management board, or a member of the management board together with a commercial proxy, are authorized to incur obligations on behalf of the company and to perform acts of disposition on behalf of the company; if a one-person management board is appointed, the President of the Management Board acts independently.

Ownership

OwnerSharesShare valueStake
100$2,701.24100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-03-02.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

9 public aid cases recorded, with a total value of $126,843.

PurposeGross amount
Regional investment aid
$77,100
De minimis aid (in accordance with Commission Regulation 2023/2831)
$9,175
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$7,996

European Funds

ProjectEU co-financing
Internationalisation of APOLLO IMPLANT COMPONENTS.
$85,730

Competitors

Name
OMET Medicalsp. z o.o.
Cytogen - Polskasp. z o.o.
Goldfarmexsp. z o.o.
Orthoactivesp. z o.o.
Tecnobody Polskasp. z o.o.
CanpolandS.A.
Geneco Groupsp. z o.o.
Novaova Sosnowski Wadowskisp. k.
Endolink PharmaS.A.
Novaovasp. z o.o.

FAQ

Last updated: 2026-10-07